Mast Financial Statements From 2010 to 2024
Mast Therapeutics financial statements provide useful quarterly and yearly information to potential Mast Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mast Therapeutics financial statements helps investors assess Mast Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mast Therapeutics' valuation are summarized below:Mast Therapeutics does not presently have any fundamental ratios for analysis.
This module can also supplement various Mast Therapeutics Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Check Mast Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mast main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Mast financial statements analysis is a perfect complement when working with Mast Therapeutics Valuation or Volatility modules.
Mast |
Mast Therapeutics Company Profit Margin Analysis
Mast Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Mast Therapeutics Profit Margin | (0.29) % |
Most of Mast Therapeutics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mast Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Mast Therapeutics has a Profit Margin of -0.2882%. This is much lower than that of the sector and significantly lower than that of the Profit Margin industry. The profit margin for all United States stocks is notably higher than that of the company.
Mast Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mast Therapeutics's current stock value. Our valuation model uses many indicators to compare Mast Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mast Therapeutics competition to find correlations between indicators driving Mast Therapeutics's intrinsic value. More Info.Mast Therapeutics is rated below average in return on asset category among related companies. It is rated below average in profit margin category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Mast Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mast Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mast Therapeutics' earnings, one of the primary drivers of an investment's value.Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Mast Stock
If you are still planning to invest in Mast Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mast Therapeutics' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |